Suraksha Diagnostic IPO sees weak response, with 37% subscription; analysts advise avoiding due to high valuation and limited market presence.
from Economic Times https://ift.tt/JWxMdp9
from Economic Times https://ift.tt/JWxMdp9
Suraksha Diagnostic IPO Day 3: GMP, Price Band, Subscription, Key Dates and Review
![Suraksha Diagnostic IPO Day 3: GMP, Price Band, Subscription, Key Dates and Review]()
Reviewed by News Today
on
December 03, 2024
Rating:
No comments: